Cingulate Announces Adjournment of Special Meeting

4 weeks ago

KANSAS CITY, Kan., Aug. 23, 2024 ( GLOBE NEWSWIRE ) -- Cingulate Inc. ( NASDAQ:CING ) , ( "Cingulate" or the "Company" ) , a biopharmaceutical company utilizing its proprietary Precision Timed Release™ ( PTR™ ) drug delivery platform technology to build and advance a pipeline of next-generation ...

Ticker	Sentiment	Impact
CING	Neutral	71 %